SUPERNUS PHARMACEUTICALS INC's ticker is SUPN and the CUSIP is 868459108. A total of 221 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q3 2016. The put-call ratio across all filers is 1.40 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2019 | $331,000 | -5.4% | 10,000 | 0.0% | 0.06% | +8.8% |
Q1 2019 | $350,000 | +5.4% | 10,000 | 0.0% | 0.06% | -8.1% |
Q4 2018 | $332,000 | -34.1% | 10,000 | 0.0% | 0.06% | -23.5% |
Q3 2018 | $504,000 | -15.9% | 10,000 | 0.0% | 0.08% | -12.9% |
Q2 2018 | $599,000 | +30.8% | 10,000 | 0.0% | 0.09% | +24.0% |
Q1 2018 | $458,000 | +14.8% | 10,000 | 0.0% | 0.08% | +23.0% |
Q4 2017 | $399,000 | -0.2% | 10,000 | 0.0% | 0.06% | +15.1% |
Q3 2017 | $400,000 | -7.2% | 10,000 | 0.0% | 0.05% | -20.9% |
Q2 2017 | $431,000 | +37.7% | 10,000 | 0.0% | 0.07% | +45.7% |
Q1 2017 | $313,000 | +23.7% | 10,000 | 0.0% | 0.05% | +2.2% |
Q4 2016 | $253,000 | +2.4% | 10,000 | 0.0% | 0.04% | +18.4% |
Q3 2016 | $247,000 | – | 10,000 | – | 0.04% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 426,500 | $11,754,340 | 3.96% |
ASHFORD CAPITAL MANAGEMENT INC | 916,747 | $25,274,715 | 3.72% |
ARMISTICE CAPITAL, LLC | 5,092,000 | $140,386,440 | 2.15% |
S&T BANK/PA | 215,578 | $5,943 | 1.15% |
Aristotle Capital Boston, LLC | 1,187,981 | $32,752,634 | 1.06% |
RICE HALL JAMES & ASSOCIATES, LLC | 544,468 | $15,010,983 | 0.95% |
Tributary Capital Management, LLC | 352,429 | $9,716,468 | 0.92% |
Bridge City Capital, LLC | 65,297 | $1,800,238 | 0.91% |
Integral Health Asset Management, LLC | 220,000 | $6,065,400 | 0.84% |
Retirement Planning Co of New England, Inc. | 51,608 | $1,422,833 | 0.79% |